Zobrazeno 1 - 5
of 5
pro vyhledávání: '"You-Meng Sun"'
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmune checkpoint inhibitors (ICIs) have dramatically altered the treatment landscape for patients with melanoma. However, their use also generates unique immune-related adverse effects (irAEs). We performed a systematic review and network
Externí odkaz:
https://doaj.org/article/6ffbceaafee148df82c68c0692191cef
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape among non-small-cell lung cancer (NSCLC) patients. The efficacy of ICI therapy in older patients (≥65 years) is controversial and not fully clarified. We perfo
Externí odkaz:
https://doaj.org/article/8172eaca411a47a3807fb542c1fd2ffa
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundImmune checkpoint inhibitors (ICIs) have dramatically altered the treatment landscape for patients with melanoma. However, their use also generates unique immune-related adverse effects (irAEs). We performed a systematic review and network
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::822a83fd6a49c068c7a76d54f861304c
https://www.frontiersin.org/articles/10.3389/fonc.2021.651553/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.651553/full
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Background: Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape among non-small-cell lung cancer (NSCLC) patients. The efficacy of ICI therapy in older patients (≥65 years) is controversial and not fully clarified. We perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45c0a88d1c9cc1ce0e6cbf50e44e441
https://www.frontiersin.org/article/10.3389/fonc.2020.558454/full
https://www.frontiersin.org/article/10.3389/fonc.2020.558454/full
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2020 (2020)
BioMed Research International, Vol 2020 (2020)
Background. Enhanced recovery after surgery (ERAS) is a multimodal, multidisciplinary, evidence-based approach to care for surgical patients and aims at optimizing the perioperative management and outcomes. The ERAS approach was first implemented in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be6713af3bdafbe541ad0b5bbae995cb